NOVEL PHARMACEUTICAL FORMULATION
Disclosed are novel pharmaceutical formulations comprising (E)-1-(4-(5-Carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-morpholinopropoxy)-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-methoxy-1H-benzo[d]imidazole-5-carboxamide, processes for p...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
17.11.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Disclosed are novel pharmaceutical formulations comprising (E)-1-(4-(5-Carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-morpholinopropoxy)-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-methoxy-1H-benzo[d]imidazole-5-carboxamide, processes for preparing the same, and methods of using the same. |
|---|---|
| AbstractList | Disclosed are novel pharmaceutical formulations comprising (E)-1-(4-(5-Carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-morpholinopropoxy)-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-methoxy-1H-benzo[d]imidazole-5-carboxamide, processes for preparing the same, and methods of using the same. |
| Author | McQUEEN, Lisa DHANIKULA, Anand Babu |
| Author_xml | – fullname: McQUEEN, Lisa – fullname: DHANIKULA, Anand Babu |
| BookMark | eNrjYmDJy89L5WRQ8PMPc_VRCPBwDPJ1dHYNDfF0dvRRcPMP8g31cQzx9PfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkZGxmZGRqbGjobGxKkCAHaYJMY |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US2022362253A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2022362253A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Sep 06 06:16:06 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2022362253A13 |
| Notes | Application Number: US201917294492 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221117&DB=EPODOC&CC=US&NR=2022362253A1 |
| ParticipantIDs | epo_espacenet_US2022362253A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20221117 |
| PublicationDateYYYYMMDD | 2022-11-17 |
| PublicationDate_xml | – month: 11 year: 2022 text: 20221117 day: 17 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED |
| RelatedCompanies_xml | – name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED |
| Score | 3.4413028 |
| Snippet | Disclosed are novel pharmaceutical formulations comprising... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | NOVEL PHARMACEUTICAL FORMULATION |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221117&DB=EPODOC&locale=&CC=US&NR=2022362253A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTQwMTdLS0nRNUoxTdE1MUwx07VITLbUNUkFNm5TLVPSLCGnffqZeYSaeEWYRjAx5MD2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1aO_YCNidMTRXc3GydQ3wd_F3VnN2tg0NVvMLAssBy2ojU2NHYF-JFdSQBp207xrmBNqXUoBcqbgJMrAFAM3LKxFiYErNE2bgdIbdvSbMwOELnfIGMqG5r1iEQcHPP8zVRyHAwzHI19HZNTQEdJaBArAb5xvqAx5qEmVQdnMNcfbQBVoVD_dZfGgwsruMxRhYgH3-VAkGhZQUk6Q0A0vzRLO0RJNkM1PLVJM0w6RkYPsgOdnC2MxYkkEGn0lS-KWlGbhAXNCWOkNzGQaWkqLSVFlg3VqSJAcOEgCCI3lX |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1akDJLdg0m6Q5BEnzIGpetEnpLSTZBASpxUb8-07WVHvqbdmB2QfM49vd-RbgIRsRVakoFcZUpgIRqSJMskITSInJbanRSvtl-wwUNyEvS3nZgfdtLQzjCf1m5IhoUQXae8389fr_EMtibys3j_kbdn08ObFu8S06HiOcEVXemup2FFqhyZumnsz5YMZk6KvHsmQgVjpQERQ2TPv2YtrUpax3g4pzAocR6lvVp9ApV33omdu_1_pw5LdX3thsrW9zBlwQLmyPi1xj5humncQNlwGHMM5PPHbUdA73jh2broBDpX8rS5P57rykC-gi5i8vgaOU5NVIUzOlykihyFpJKjEvMD8oiomkSAMY7tN0tV98Bz039r3Uew5er-G4ETXldaI6hG79-VXeYJyt81u2PT9Uk3xC |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+PHARMACEUTICAL+FORMULATION&rft.inventor=McQUEEN%2C+Lisa&rft.inventor=DHANIKULA%2C+Anand+Babu&rft.date=2022-11-17&rft.externalDBID=A1&rft.externalDocID=US2022362253A1 |